Skip to content

Clinical trials

Mood Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: Poland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20112
20121
20141
20191
20203
20211
20221
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Unknown status2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Wroclaw University of Health and Sport Sciences4
Eli Lilly and Company2
Seaport Therapeutics2
Takeda2
Novartis Pharmaceuticals1
Poznan University of Physical Education1
The Opole University of Technology1
University of Social Sciences and Humanities, Warsaw1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders18
Major Depressive Disorder11
Depressive Disorder10
Anxiety Disorders7
Mental Disorders6
Cardiovascular Diseases3
Coronary Artery Disease3
Pulmonary Disease, Chronic Obstructive2
Dysthymic Disorder1
Lung Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.